Name | N-(4-chlorophenyl)-2-(pyridin-4-ylmethylamino)benzamide |
---|---|
Synonyms |
HMS3229O07
VEGF Receptor Tyrosine Kinase Inhibitor II |
Description | VEGFR-IN-1 (compound 3) is a potent angiogenesis inhibitor with IC50s of 0.02, 0.18, 0.24 7.3, and 7 µM for KDR, Flt-1, c-Kit, EGF-R, and c-Src, respectively[1]. |
---|---|
Related Catalog | |
Target |
KDR:0.02 μM (IC50) Flt-1:0.18 μM (IC50) EGFR:0.24 μM (IC50) |
References |
Molecular Formula | C19H16ClN3O |
---|---|
Molecular Weight | 337.80300 |
Exact Mass | 337.09800 |
PSA | 54.02000 |
LogP | 4.74540 |